trial · primary record
AMG 510
Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 13 |
| Primary completion | 2027-10-20 |
| Primary endpoint | Patients with surgically resectable KRAS p.G12C-mutant non-squamous NSCLC as assessed by major pathologic response rate in resected tumor specimens |
| Registry ID | NCT05118854 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:52.963Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05118854
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.